Dipeptide inhibitors of angiogenesis

Research output: Patent

View graph of relations Save citation



Research units


The present invention relates to inhibitors of tissue transglutaminase for use in the inhibition of angiogenesis in a subject. In particular, the invention provides compounds of Formula I for use in the treatment and/or prevention of angiogenic diseases and disorders of the eye, such as diabetic retinopathy and age-related macular degeneration (AMD). The invention further provides methods for inhibiting angiogenesis in a subject.


Original languageEnglish
Patent numberGB 1107576.9
Publication statusPublished - 6 May 2011

Employable Graduates; Exploitable Research

Copy the text from this field...